Meral Esen

Sterile protection against human malaria by chemoattenuated PfSPZ vaccine

Benjamin Mordmüller, Güzin Surat, Heimo Lagler et al. · Nature · 2017 · 412 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 175 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Virology +16

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2

Peter G. Kremsner, Philipp Mann, Arne Kroidl et al. · Wiener klinische Wochenschrift · 2021 · 132 citations · Full text

Veterinary Medicine, Immunology, Molecular Pharmaceutics +17

Lymphotoxin and lipopolysaccharide induce NF‐κB‐p52 generation by a co‐translational mechanism

Benjamin Mordmüller, Daniel Krappmann, Meral Esen et al. · EMBO Reports · 2003 · 129 citations · Full text

Life Sciences, Cell Biology, Immunology +11

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

Dorothee Kieninger, Eric Sheldon, Wen‐Yuan Lin et al. · BMC Infectious Diseases · 2013 · 104 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +11